Q9969 HCPCS Level II code: Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose
CMS terminated Q9969: its last date of service was Dec 31, 2025. It stays here for looking up older claims; newer services need a current code.
Official description
Q9969Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose
Short description: Non-heu tc-99m add-on/dose
HCPCS · United States
Notes for Q9969
As CMS prints them, with any note Q9969 takes from the headings above it.
Note
- CMS processing note 0179: CY 2013 OPPS/ASC FINAL RULE.
Medicare details
The indicators CMS publishes with Q9969 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Statute
- Type of service
- Other medical items or services
- BETOS category
- Other - Medicare fee schedule
- Added
- Jan 1, 2013
- Terminated after
- Dec 31, 2025
Where Q9969 sits
- 1Q codesTemporary codes
- 2Terminated Q9969Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code Q9969 still valid?
No. CMS terminated Q9969; its last date of service was Dec 31, 2025. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover Q9969?
CMS lists Q9969’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Statute”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside Q9969
All Q codesQ9963High osmolar contrast material, 350-399 mg/ml iodine concentration, per mlQ9964High osmolar contrast material, 400 or greater mg/ml iodine concentration, per mlQ9965Low osmolar contrast material, 100-199 mg/ml iodine concentration, per mlQ9966Low osmolar contrast material, 200-299 mg/ml iodine concentration, per mlQ9967Low osmolar contrast material, 300-399 mg/ml iodine concentration, per mlQ9968Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mgQ9970Injection, ferric carboxymaltose, 1mgQ9972Injection, epoetin beta, 1 microgram, (for esrd on dialysis)Q9973Injection, epoetin beta, 1 microgram, (non-esrd use)Q9974Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mgQ9975Injection, factor viii fc fusion protein (recombinant), per iuQ9976Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron